🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kathleen P. Pratt

Uniformed Services University of the Health Sciences

ORCID: 0000-0001-6837-6133
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.618Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19

Human Vaccines & Immunotherapeutics(2022)10.1080/21645515.2022.2048622
Top 32%
0.618DataRank
Top 32%17 citations

Pooja Vir, Ahmad Faisal Karim, Swagata Kar, Dalia Benetiene, Megan Lok +7 more

Papers

Driven by 8 papers — median percentile 68. Top paper: “Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19”.

Human-Immune-System (HIS) humanized mouse model (DRAGA: HLA-A2.HLA-DR4.Rag1KO.IL-2RγcKO.NOD) for COVID-19

Human Vaccines & Immunotherapeutics(2022)10.1080/21645515.2022.2048622
Top 32%
0.618DataRank
Top 32%17 citations

Pooja Vir, Ahmad Faisal Karim, Swagata Kar, Dalia Benetiene, Megan Lok +7 more

The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections

Human Vaccines & Immunotherapeutics(2020)10.1080/21645515.2020.1713605
N/A
0.434DataRank · unranked
17 citations

Devi Gunasekera, Kathleen P. Pratt, Qi Qiu, Sofía Casares, Teodor‐D. Brumeanu +1 more

Anti-FVIII antibodies in Black and White hemophilia A subjects: do F8 haplotypes play a role?

Blood Advances(2022)10.1182/bloodadvances.2021004909
N/A
0.241DataRank · unranked
4 citations

Devi Gunasekera, Pooja Vir, Siyuan Tan, Glenn F. Pierce, Cara Olsen +3 more

Editorial: Tolerating Factor VIII: Novel Strategies to Prevent and Reverse Neutralizing Anti-FVIII Antibodies

Frontiers in Immunology(2021)10.3389/fimmu.2020.639386
N/A
0.104DataRank · unranked
1 citations

Kathleen P. Pratt, Sébastien Lacroix‐Desmazes

Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers

BMC Infectious Diseases(2021)10.1186/s12879-021-06233-1
N/A
0DataRank · unranked
26 citations

Emilie Goguet, Eric D. Laing, Cara Olsen, Simon Pollett, Monique Hollis-Perry +27 more

Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies

Frontiers in Immunology(2020)10.3389/fimmu.2019.03078
N/A
0DataRank · unranked
21 citations

Kathleen P. Pratt, David W. Scott

Inhibitors—Recent insights

Haemophilia(2020)10.1111/hae.14077
N/A
0DataRank · unranked
15 citations

Valder R. Arruda, Sébastien Lacroix‐Desmazes, Kathleen P. Pratt

Tolerating Factor VIII: Recent Progress

Frontiers in Immunology(2020)10.3389/fimmu.2019.02991
N/A
0DataRank · unranked
70 citations

Jan Voorberg, David Lillicrap, David W. Scott, Kathleen P. Pratt, Sébastien Lacroix‐Desmazes